Skip to main content
. 2018 Aug 8;132(18):1974–1984. doi: 10.1182/blood-2018-05-846592

Figure 4.

Figure 4.

Effect of naturally occurring VKOR mutations on VKOR activity and KO binding. (A) Cell-based VKOR activity of all naturally occurring VKOR mutations. Each VKOR mutation was transiently expressed in DGKO FIXgla-PC/HEK293 reporter cells; the transfected cells were cultured with 5 µM KO for activity assay. Bar color codes are the same as in Figure 2. Wild-type VKOR activity is indicated by the dotted line. (B) KO concentration titration of wild-type VKOR transiently expressed in DGKO FIXgla-PC/HEK293 reporter cells. The EC50 of KO was determined by GraphPad software. (C) The EC50 of KO for all naturally occurring VKOR mutations. Data are presented as mean ± SD. Bar color codes are the same as Figure 2. The EC50 of the wild-type VKOR is indicated by the dotted line. (D) Correlation between IC50 of warfarin and EC50 of KO for naturally occurring VKOR mutations. Data for the Y139H mutant were excluded for the correlation calculation.